000 03525nam  2200325zi 4500
0019.895489
003CaOODSP
00520221107174036
007cr |n|||||||||
008210120s1993    onc     o    f000 0 eng d
040 |aCaOODSP|beng
043 |an-cn---
086 |aZ1-1989/3-1E-PDF
1101 |aCanada.|bRoyal Commission on New Reproductive Technologies, |eauthor. |eissuing body.
24510|aProceed with care : |bfinal report of the Royal Commission on New Reproductive Technologies : main topics.
24610|aFinal report of the Royal Commission on New Reproductive Technologies : |bmain topics
264 1|aOttawa, Canada : |bRoyal Commission on New Reproductive Technologies = Commission royale sur les nouvelles techniques de reproduction, |c[1993]
300 |a1 online resource (1 volume (various pagings))
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aDigitized edition from print [produced by Privy Council Canada].
500 |aIssued also in French under title: Un virage à prendre en douceur : rapport final de la Commission royale sur les nouvelles techniques de reproduction : résumé des principaux sujets traités.
5050 |aIntroduction -- How the Commission Went About Its Work -- Responsible Regulation : The National Reproductive Technologies Commission -- New Reproductive Technologies and the Health Care System -- Ethical Framework and Guiding Principles -- The Prevalence of Infertility -- Sexually Transmitted Diseases and Infertility -- Smoking and Infertility -- Age and Infertility -- Exposure to Harmful Agents in the Workplace and the Environment and Infertility -- Preventing Infertility -- Adoption -- Fertility Drugs -- Assisted Insemination -- In Vitro Fertilization -- Handling of Eggs and Embryos -- Embryo Research -- Preconception Arrangements -- Commercial Interests -- Prenatal Diagnosis for Congenital Anomalies and Genetic Disease -- Prenatal Diagnosis for Late-Onset Single-Gene Disorders and Prenatal Diagnosis for Susceptibility Genes -- Sex Selection for Non-Medical Reasons -- Gene Therapy and Genetic Alteration -- Judicial Intervention -- Uses of Fetal Tissues -- Conclusion.
520 |a"Having children and ensuring they are healthy are fundamentally important goals to most Canadians, but some people cannot reach these goals without help. As a caring society, Canada should respond to these deeply held aspirations, but the technology used to help can also be misused, and have harmful consequences both for individuals and for society. National action is needed to ensure new reproductive technologies are not misused, but used with care. It is the responsibility of the federal government, on behalf of society, to set boundaries around the technologies prohibiting those that contravene Canadian ethical and social values, and to put in place regulation to ensure that only legitimate, beneficial uses occur. Only the federal government has the power to put in place a system to manage the technologies. In the interest of protecting Canadian citizens, the federal government has the responsibility to do so"--Introduction.
650 0|aHuman reproductive technology|zCanada.
650 0|aInfertility|xTreatment|zCanada.
650 0|aEmbryology, Human|zCanada.
77508|tUn virage à prendre en douceur : |w(CaOODSP)9.895493
85640|qPDF|s30.76 MB|uhttps://publications.gc.ca/collections/collection_2021/bcp-pco/Z1-1989-3/Z1-1989-3-1-eng.pdf